Impact of comorbidities in pulmonary rehabilitation outcomes in patients with chronic obstructive pulmonary disease.
about
Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON studyInfluence of comorbidities on the efficacy of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.The influence of comorbidities on outcomes of pulmonary rehabilitation programs in patients with COPD: a systematic reviewMultimorbidity, frailty and chronic obstructive pulmonary disease: Are the challenges for pulmonary rehabilitation in the name?Echocardiographic abnormalities and their impact on health status in patients with COPD referred for pulmonary rehabilitation.
P2860
Impact of comorbidities in pulmonary rehabilitation outcomes in patients with chronic obstructive pulmonary disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Impact of comorbidities in pul ...... obstructive pulmonary disease.
@en
Impact of comorbidities in pul ...... obstructive pulmonary disease.
@nl
type
label
Impact of comorbidities in pul ...... obstructive pulmonary disease.
@en
Impact of comorbidities in pul ...... obstructive pulmonary disease.
@nl
prefLabel
Impact of comorbidities in pul ...... obstructive pulmonary disease.
@en
Impact of comorbidities in pul ...... obstructive pulmonary disease.
@nl
P1476
Impact of comorbidities in pul ...... obstructive pulmonary disease
@en
P2093
P304
P356
10.1016/J.RPPNEU.2012.12.004
P577
2013-05-09T00:00:00Z